6 completed. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 3 |
Follow solabegron: new trials by email Literature Review of solabegron trials Research Report on solabegron
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women Solabegron immediate release tablets, low dose, Solabegron immediate release tablets, high dose, Matching Placebo - Overactive Bladder | Phase 2 | Completed | Velicept Therapeutics, Inc. | 438 | 2018-02-19 | 2020-03-02 |
| A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder solabegron and oxybutynin - Overactive Bladder | Phase 1 | Completed | GlaxoSmithKline | 24 | 2007-06-01 | 2015-04-15 |
| A Two-Part Study to Determine: Best Medication Formulation and Food Effect Solabegron - Overactive Bladder | Phase 1 | Completed | GlaxoSmithKline | 18 | 2007-01-01 | 2008-10-07 |
| A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers Placebo, Solabegron (GW427353) - Irritable Bowel Syndrome (IBS) | Phase 1 | Completed | GlaxoSmithKline | 36 | 2006-10-01 | 2008-10-16 |
| A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS) GW427353, Placebo - Irritable Bowel Syndrome (IBS) | Phase 2 | Completed | GlaxoSmithKline | 100 | 2006-08-01 | 2009-05-18 |
| Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms Solabegron - Overactive Bladder | Phase 2 | Completed | GlaxoSmithKline | 240 | 2006-05-01 | 2009-05-18 |
Urinary Bladder, Overactive (4) · Irritable Bowel Syndrome (2)
GlaxoSmithKline (5) · Velicept Therapeutics, Inc. (1)
United States (4) · Australia (2) · France (2) · Germany (2) · Argentina (1) · Finland (1) · Latvia (1) · Netherlands (1) · New Zealand (1) · Poland (1) · Slovenia (1) · South Africa (1) · South Korea (1) · Spain (1) · Taiwan (1)